Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.
about
Immunoregulation in human American leishmaniasis: balancing pathology and protectionCoating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy against Leishmania in hamsters by inducing Th1-type immune responsesMycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensisAnti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance.Clinical and experimental advances in treatment of visceral leishmaniasis.Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi.Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleenImmunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor beta antibodyImpact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.Role for nitric oxide in hookworm-associated immune suppression.Immunomodulation in human dendritic cells leads to induction of interferon-gamma production by Leishmania donovani derived KMP-11 antigen via activation of NF-κB in Indian kala-azar patientsReal-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis.
P2860
Q26850280-26CDD2C4-FA06-48F7-8782-F8AAC3891E0EQ28383050-7356D28B-B797-4FFF-A52F-52C764A56AF8Q28480989-464B3DBB-0DCA-44AB-B8FE-C01120CD27D8Q28483691-F7FB068D-8848-4D70-AF1A-57C4545DDFF1Q33849243-1AD5107F-F765-4F1B-92EF-0D53EC9F2E0EQ33982648-1D5E9602-9932-4A34-906A-19AB4E43FCF7Q34005039-A8C5624A-8962-4FCA-969B-0457EE9DEEAAQ34462414-211A1623-82DF-4AFD-9EF3-CBD8216F295AQ34637852-C7F93881-C31A-418B-AC04-9924972BFB03Q34934364-36411F94-8536-447B-A214-5D3503467ADFQ36111326-05D0E166-30C8-4571-803E-606330222E8BQ36710725-ACC1E4C7-3519-42A5-A3BB-998C9EF33B44Q41939228-043FB5AA-DCC2-436C-BB6F-930F60BF0B60Q42112456-9ABF1543-96D0-41EA-A092-DAB1A2543386Q55709058-A3D9CB71-AC28-4E4D-B837-6732C09DB111
P2860
Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Transforming growth factor bet ...... mental visceral leishmaniasis.
@en
Transforming growth factor bet ...... mental visceral leishmaniasis.
@nl
type
label
Transforming growth factor bet ...... mental visceral leishmaniasis.
@en
Transforming growth factor bet ...... mental visceral leishmaniasis.
@nl
prefLabel
Transforming growth factor bet ...... mental visceral leishmaniasis.
@en
Transforming growth factor bet ...... mental visceral leishmaniasis.
@nl
P2093
P2860
P1476
Transforming growth factor bet ...... imental visceral leishmaniasis
@en
P2093
A Campos-Neto
J Santana da Silva
V Rodrigues
P2860
P304
P407
P577
1998-03-01T00:00:00Z